Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xencor, Inc.

Clinical trials sponsored by Xencor, Inc., explained in plain language.

Xencor, Inc. XNCR NASDAQ

Biotech engineering antibody therapeutics for cancer and autoimmune diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 7 Completed 1 Terminated 2

New drug combo shows promise for Tough-to-Treat prostate cancer

Disease control Completed

This Phase 2 trial tested an immunotherapy drug called vudalimab, either by itself or combined with standard chemotherapy or targeted therapy, in 72 men with metastatic castration-resistant prostate cancer that had worsened after prior treatments. The main goal was to check safet…

Phase: PHASE2 • Sponsor: Xencor, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC